Oramed Pharmaceuticals (ORMP) Operating Leases (2019 - 2026)
Oramed Pharmaceuticals (ORMP) posted Operating Leases of $493000.0 for Q1 2026, down 8.7% on a QoQ basis from $540000.0 in Q4 2025, and up 310.83% year-over-year from $120000.0 in Q1 2025.
Oramed Pharmaceuticals (ORMP) Operating Leases (2019 - 2026) Analysis & Trends
Oramed Pharmaceuticals' Operating Leases history runs 8 years deep, the most recent figure standing at $493000.0 for Q1 2026.
- Quarterly Operating Leases rose 310.83% year-over-year to $493000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $493000.0 (up 310.83% YoY) and the FY2025 annual result came in at $540000.0, up 246.15% from the prior year.
- Operating Leases was $493000.0 for Q1 2026 at Oramed Pharmaceuticals, down from $540000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $1.1 million in Q1 2022 and bottomed at $120000.0 in Q1 2025.
- A 5-year average of $482000.0 and a median of $493000.0 in 2026 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2025 — Operating Leases sank 55.88% — and 2026, when it surged 310.83%.
- Oramed Pharmaceuticals' Operating Leases stood at $647000.0 in 2022, then tumbled by 47.14% to $342000.0 in 2023, then slumped by 54.39% to $156000.0 in 2024, then surged by 246.15% to $540000.0 in 2025, then slipped by 8.7% to $493000.0 in 2026.
- Business Quant data shows ORMP's Operating Leases at $493000.0 in Q1 2026, $540000.0 in Q4 2025, and $589000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 493,000.00 |
| Dec 31, 2025 | 540,000.00 |
| Sep 30, 2025 | 589,000.00 |
| Jun 30, 2025 | 648,000.00 |
| Mar 31, 2025 | 120,000.00 |
| Dec 31, 2024 | 156,000.00 |
| Sep 30, 2024 | 186,000.00 |
| Jun 30, 2024 | 236,000.00 |
| Mar 31, 2024 | 272,000.00 |
| Dec 31, 2023 | 342,000.00 |
| Sep 30, 2023 | 389,000.00 |
| Jun 30, 2023 | 488,000.00 |
| Mar 31, 2023 | 564,000.00 |
| Dec 31, 2022 | 647,000.00 |
| Sep 30, 2022 | 672,000.00 |
| Jun 30, 2022 | 744,000.00 |
| Mar 31, 2022 | 1.11 Mn |
| Nov 30, 2021 | 374,000.00 |
| Aug 31, 2021 | 533,000.00 |
| May 31, 2021 | 431,000.00 |